シカゴ優先度尺度を用いたHPV誘発口腔がんにおける患者優先度評価:将来の臨床試験設計に関する考察
PubMedで要約を見る
まとめ
この要約は機械生成です。ヒトパピローマウイルス関連口がん (HPVOPC) の治療の患者優先順位は,化学放射線療法前と後の治療に一貫しています. HPVOPCの生存者にとって,飲み込み,感覚,口の水分がより重要になる.
科学分野
- 腫瘍学
- 頭頸部がんの研究
- 患者による報告結果
背景
- ヒトパピローマウイルス関連口腔がん (HPVOPC) は,頭頸部がんの別種のサブタイプである.
- 治療の優先順位は,腫瘍学的治療の間に,そしてその後に進化することができます.
- 患者の優先順位を理解することは 治療とサポートケアを 合わせるのに不可欠です
研究 の 目的
- 化学放射線療法 (CRT) の前と12ヶ月後のHPVOPC患者の治療結果の優先順位を評価する.
- 治療後の治療,生存,生活の質に関する患者の優先順位の変化を特定する.
- HPVOPCの将来の緩和治療戦略の開発に情報を提供すること.
主な方法
- 治療目的のプライマリCRTを受けているHPVOPC患者群を研究した.
- シカゴ・プライオリティ・スケール (CPS修正) とMDASIヘッド・アンド・ネック・ガン・モジュール (MDASI- HN) を投与した.
- 記述的統計と統計的テスト (マクネマール,一般的な線形モデル) が分析に使用された.
主要な成果
- 癌の治癒と生存率のような主要な優先順位は,CRT前と後に安定したままでした.
- 飲み込む能力は,CRT後の患者の56%にとって最優先事項でした.
- 味覚 (味覚/嗅覚) とCRT後の口の水分感の重要性が増加した.
結論
- HPVOPC患者に対する治療結果の優先順位は,CRT前と12ヶ月後にほぼ安定しています.
- 治療後の飲み込み,感覚,口の水分を優先しています.
- 患者中心の優先順位は,HPVOPC管理における将来の緩和戦略の設計を導くべきです.
関連する概念動画
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

